ID   LRSM1_HUMAN             Reviewed;         723 AA.
AC   Q6UWE0; Q5VVV0; Q8NB40; Q96GT5; Q96MX5; Q96MZ7;
DT   01-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   10-MAY-2017, entry version 140.
DE   RecName: Full=E3 ubiquitin-protein ligase LRSAM1 {ECO:0000305};
DE            EC=2.3.2.27 {ECO:0000269|PubMed:15256501, ECO:0000269|PubMed:23245322};
DE   AltName: Full=Leucine-rich repeat and sterile alpha motif-containing protein 1 {ECO:0000303|PubMed:20865121};
DE   AltName: Full=RING-type E3 ubiquitin transferase LRSAM1 {ECO:0000305};
DE   AltName: Full=Tsg101-associated ligase {ECO:0000303|PubMed:15256501};
DE            Short=hTAL {ECO:0000303|PubMed:15256501};
GN   Name=LRSAM1 {ECO:0000303|PubMed:20865121};
GN   Synonyms=TAL {ECO:0000303|PubMed:15256501}; ORFNames=UNQ6496/PRO21356;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Brain, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ASP-318.
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, DOMAIN, AND MUTAGENESIS OF CYS-675;
RP   HIS-692 AND 649-PRO--PRO-664.
RX   PubMed=15256501; DOI=10.1101/gad.294904;
RA   Amit I., Yakir L., Katz M., Zwang Y., Marmor M.D., Citri A.,
RA   Shtiegman K., Alroy I., Tuvia S., Reiss Y., Roubini E., Cohen M.,
RA   Wides R., Bacharach E., Schubert U., Yarden Y.;
RT   "Tal, a Tsg101-specific E3 ubiquitin ligase, regulates receptor
RT   endocytosis and retrovirus budding.";
RL   Genes Dev. 18:1737-1752(2004).
RN   [6]
RP   INTERACTION WITH TSG101.
RX   PubMed=17556548; DOI=10.1126/science.1143422;
RA   Carlton J.G., Martin-Serrano J.;
RT   "Parallels between cytokinesis and retroviral budding: a role for the
RT   ESCRT machinery.";
RL   Science 316:1908-1912(2007).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-234 AND SER-604, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   INVOLVEMENT IN CMT2P.
RX   PubMed=20865121; DOI=10.1371/journal.pgen.1001081;
RA   Guernsey D.L., Jiang H., Bedard K., Evans S.C., Ferguson M.,
RA   Matsuoka M., Macgillivray C., Nightingale M., Perry S., Rideout A.L.,
RA   Orr A., Ludman M., Skidmore D.L., Benstead T., Samuels M.E.;
RT   "Mutation in the gene encoding ubiquitin ligase LRSAM1 in patients
RT   with Charcot-Marie-Tooth disease.";
RL   PLoS Genet. 6:E1001081-E1001081(2010).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-604, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=23245322; DOI=10.1016/j.chom.2012.10.019;
RA   Huett A., Heath R.J., Begun J., Sassi S.O., Baxt L.A., Vyas J.M.,
RA   Goldberg M.B., Xavier R.J.;
RT   "The LRR and RING domain protein LRSAM1 is an E3 ligase crucial for
RT   ubiquitin-dependent autophagy of intracellular Salmonella
RT   Typhimurium.";
RL   Cell Host Microbe 12:778-790(2012).
RN   [12]
RP   TISSUE SPECIFICITY, AND INVOLVEMENT IN CMT2P.
RX   PubMed=22012984; DOI=10.1093/hmg/ddr471;
RA   Weterman M.A., Sorrentino V., Kasher P.R., Jakobs M.E.,
RA   van Engelen B.G., Fluiter K., de Wissel M.B., Sizarov A., Nurnberg G.,
RA   Nurnberg P., Zelcer N., Schelhaas H.J., Baas F.;
RT   "A frameshift mutation in LRSAM1 is responsible for a dominant
RT   hereditary polyneuropathy.";
RL   Hum. Mol. Genet. 21:358-370(2012).
RN   [13]
RP   INTERACTION WITH PHF23, FUNCTION, AND UBIQUITINATION.
RX   PubMed=25484098; DOI=10.4161/auto.36439;
RA   Wang Z., Hu J., Li G., Qu L., He Q., Lou Y., Song Q., Ma D., Chen Y.;
RT   "PHF23 (plant homeodomain finger protein 23) negatively regulates cell
RT   autophagy by promoting ubiquitination and degradation of E3 ligase
RT   LRSAM1.";
RL   Autophagy 10:2158-2170(2014).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   VARIANT CMT2P ARG-694, CHARACTERIZATION OF VARIANT CMT2P ARG-694,
RP   INTERACTION WITH FUS, AND SUBCELLULAR LOCATION.
RX   PubMed=27615052; DOI=10.1002/ana.24776;
RA   Hu B., Arpag S., Zuchner S., Li J.;
RT   "A novel missense mutation of CMT2P alters transcription machinery.";
RL   Ann. Neurol. 80:834-845(2016).
RN   [16]
RP   VARIANT CMT2P TYR-694, AND CHARACTERIZATION OF VARIANT CMT2P TYR-694.
RX   PubMed=27686364; DOI=10.1002/ana.24775;
RA   Peeters K., Palaima P., Pelayo-Negro A.L., Garcia A., Gallardo E.,
RA   Garcia-Barredo R., Mateiu L., Baets J., Menten B., De Vriendt E.,
RA   De Jonghe P., Timmerman V., Infante J., Berciano J., Jordanova A.;
RT   "Charcot-Marie-Tooth disease type 2G redefined by a novel mutation in
RT   LRSAM1.";
RL   Ann. Neurol. 80:823-833(2016).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that mediates
CC       monoubiquitination of TSG101 at multiple sites, leading to
CC       inactivate the ability of TSG101 to sort endocytic (EGF receptors)
CC       and exocytic (HIV-1 viral proteins) cargos (PubMed:15256501).
CC       Bacterial recognition protein that defends the cytoplasm from
CC       invasive pathogens (PubMed:23245322). Localizes to several
CC       intracellular bacterial pathogens and generates the bacteria-
CC       associated ubiquitin signal leading to autophagy-mediated
CC       intracellular bacteria degradation (xenophagy) (PubMed:23245322,
CC       PubMed:25484098). {ECO:0000269|PubMed:15256501,
CC       ECO:0000269|PubMed:23245322, ECO:0000269|PubMed:25484098}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine. {ECO:0000269|PubMed:15256501,
CC       ECO:0000269|PubMed:23245322}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000269|PubMed:15256501, ECO:0000269|PubMed:23245322}.
CC   -!- SUBUNIT: Interacts with TSG101 (PubMed:17556548). Interacts with
CC       PHF23 (PubMed:25484098). Interacts with FUS (PubMed:27615052).
CC       {ECO:0000269|PubMed:17556548, ECO:0000269|PubMed:25484098,
CC       ECO:0000269|PubMed:27615052}.
CC   -!- INTERACTION:
CC       P54274:TERF1; NbExp=2; IntAct=EBI-720984, EBI-710997;
CC       Q99816:TSG101; NbExp=9; IntAct=EBI-720984, EBI-346882;
CC       P61088:UBE2N; NbExp=3; IntAct=EBI-720984, EBI-1052908;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15256501,
CC       ECO:0000269|PubMed:27615052}. Note=Displays a punctuate
CC       distribution and localizes to a submembranal ring
CC       (PubMed:15256501). Localizes to intracellular bacterial pathogens
CC       (PubMed:23245322). {ECO:0000269|PubMed:15256501,
CC       ECO:0000269|PubMed:23245322}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q6UWE0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6UWE0-2; Sequence=VSP_012661;
CC       Name=3;
CC         IsoId=Q6UWE0-3; Sequence=VSP_012660;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in adult spinal cord
CC       motoneurons as well as in fetal spinal cord and muscle tissue.
CC       {ECO:0000269|PubMed:22012984}.
CC   -!- DOMAIN: The coiled coil domains interact with the SB domain of
CC       TSG101. {ECO:0000269|PubMed:15256501}.
CC   -!- DOMAIN: The PTAP motifs mediate the binding to UEV domains.
CC       {ECO:0000269|PubMed:15256501}.
CC   -!- DOMAIN: The LRR domain is necessary and sufficient for
CC       localization to bacterial targets. {ECO:0000269|PubMed:23245322}.
CC   -!- DOMAIN: The RING domain is required for ubiquitination.
CC       {ECO:0000269|PubMed:23245322}.
CC   -!- PTM: Ubiquitination promoted by PHF23 leads to proteasomal
CC       degradation. {ECO:0000269|PubMed:25484098}.
CC   -!- DISEASE: Charcot-Marie-Tooth disease 2P (CMT2P) [MIM:614436]: An
CC       axonal form of Charcot-Marie-Tooth disease, a disorder of the
CC       peripheral nervous system, characterized by progressive weakness
CC       and atrophy, initially of the peroneal muscles and later of the
CC       distal muscles of the arms. Charcot-Marie-Tooth disease is
CC       classified in two main groups on the basis of electrophysiologic
CC       properties and histopathology: primary peripheral demyelinating
CC       neuropathies (designated CMT1 when they are dominantly inherited)
CC       and primary peripheral axonal neuropathies (CMT2). Neuropathies of
CC       the CMT2 group are characterized by signs of axonal degeneration
CC       in the absence of obvious myelin alterations, normal or slightly
CC       reduced nerve conduction velocities, and progressive distal muscle
CC       weakness and atrophy. Nerve conduction velocities are normal or
CC       slightly reduced. {ECO:0000269|PubMed:20865121,
CC       ECO:0000269|PubMed:22012984, ECO:0000269|PubMed:27615052,
CC       ECO:0000269|PubMed:27686364}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY358830; AAQ89189.1; -; mRNA.
DR   EMBL; AK056203; BAB71119.1; -; mRNA.
DR   EMBL; AK056305; BAB71144.1; -; mRNA.
DR   EMBL; AK091589; BAC03703.1; -; mRNA.
DR   EMBL; AL445222; CAH72930.1; -; Genomic_DNA.
DR   EMBL; AL445222; CAH72931.1; -; Genomic_DNA.
DR   EMBL; BC009239; AAH09239.1; -; mRNA.
DR   CCDS; CCDS55347.1; -. [Q6UWE0-2]
DR   CCDS; CCDS6873.1; -. [Q6UWE0-1]
DR   RefSeq; NP_001005373.1; NM_001005373.3. [Q6UWE0-1]
DR   RefSeq; NP_001005374.1; NM_001005374.3. [Q6UWE0-1]
DR   RefSeq; NP_001177652.1; NM_001190723.2. [Q6UWE0-2]
DR   RefSeq; NP_612370.3; NM_138361.5. [Q6UWE0-1]
DR   RefSeq; XP_016870772.1; XM_017015283.1. [Q6UWE0-1]
DR   UniGene; Hs.495188; -.
DR   ProteinModelPortal; Q6UWE0; -.
DR   BioGrid; 124754; 54.
DR   IntAct; Q6UWE0; 39.
DR   MINT; MINT-1377718; -.
DR   STRING; 9606.ENSP00000300417; -.
DR   iPTMnet; Q6UWE0; -.
DR   PhosphoSitePlus; Q6UWE0; -.
DR   BioMuta; LRSAM1; -.
DR   DMDM; 62511890; -.
DR   EPD; Q6UWE0; -.
DR   MaxQB; Q6UWE0; -.
DR   PaxDb; Q6UWE0; -.
DR   PeptideAtlas; Q6UWE0; -.
DR   PRIDE; Q6UWE0; -.
DR   Ensembl; ENST00000300417; ENSP00000300417; ENSG00000148356. [Q6UWE0-1]
DR   Ensembl; ENST00000323301; ENSP00000322937; ENSG00000148356. [Q6UWE0-1]
DR   Ensembl; ENST00000373322; ENSP00000362419; ENSG00000148356. [Q6UWE0-1]
DR   Ensembl; ENST00000373324; ENSP00000362421; ENSG00000148356. [Q6UWE0-2]
DR   GeneID; 90678; -.
DR   KEGG; hsa:90678; -.
DR   UCSC; uc004brb.2; human. [Q6UWE0-1]
DR   CTD; 90678; -.
DR   DisGeNET; 90678; -.
DR   GeneCards; LRSAM1; -.
DR   GeneReviews; LRSAM1; -.
DR   HGNC; HGNC:25135; LRSAM1.
DR   HPA; CAB037304; -.
DR   HPA; HPA021403; -.
DR   HPA; HPA021844; -.
DR   MalaCards; LRSAM1; -.
DR   MIM; 610933; gene.
DR   MIM; 614436; phenotype.
DR   neXtProt; NX_Q6UWE0; -.
DR   OpenTargets; ENSG00000148356; -.
DR   Orphanet; 300319; Autosomal dominant Charcot-Marie-Tooth disease type 2P.
DR   PharmGKB; PA134890010; -.
DR   eggNOG; KOG0619; Eukaryota.
DR   eggNOG; COG4886; LUCA.
DR   GeneTree; ENSGT00840000129676; -.
DR   HOGENOM; HOG000231972; -.
DR   HOVERGEN; HBG052363; -.
DR   InParanoid; Q6UWE0; -.
DR   KO; K10641; -.
DR   OMA; FGAFATC; -.
DR   OrthoDB; EOG091G02SW; -.
DR   PhylomeDB; Q6UWE0; -.
DR   TreeFam; TF329645; -.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; LRSAM1; human.
DR   GeneWiki; LRSAM1; -.
DR   GenomeRNAi; 90678; -.
DR   PRO; PR:Q6UWE0; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000148356; -.
DR   CleanEx; HS_LRSAM1; -.
DR   ExpressionAtlas; Q6UWE0; baseline and differential.
DR   Genevisible; Q6UWE0; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IDA:GO_Central.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006914; P:autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0045806; P:negative regulation of endocytosis; IMP:UniProtKB.
DR   GO; GO:2000786; P:positive regulation of autophagosome assembly; IMP:GO_Central.
DR   GO; GO:1904417; P:positive regulation of xenophagy; IMP:GO_Central.
DR   GO; GO:0051865; P:protein autoubiquitination; IDA:UniProtKB.
DR   GO; GO:0030163; P:protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; IDA:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   GO; GO:0070086; P:ubiquitin-dependent endocytosis; IDA:UniProtKB.
DR   GO; GO:0046755; P:viral budding; IMP:UniProtKB.
DR   CDD; cd00162; RING; 1.
DR   Gene3D; 3.80.10.10; -; 2.
DR   InterPro; IPR032675; L_dom-like.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed.
DR   InterPro; IPR001841; Znf_RING.
DR   Pfam; PF13855; LRR_8; 1.
DR   Pfam; PF07647; SAM_2; 1.
DR   SMART; SM00369; LRR_TYP; 4.
DR   SMART; SM00454; SAM; 1.
DR   SUPFAM; SSF47769; SSF47769; 1.
DR   SUPFAM; SSF52058; SSF52058; 1.
DR   PROSITE; PS51450; LRR; 4.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Autophagy; Charcot-Marie-Tooth disease;
KW   Coiled coil; Complete proteome; Cytoplasm; Disease mutation;
KW   Leucine-rich repeat; Metal-binding; Neurodegeneration; Neuropathy;
KW   Phosphoprotein; Polymorphism; Protein transport; Reference proteome;
KW   Repeat; Transferase; Transport; Ubl conjugation;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1    723       E3 ubiquitin-protein ligase LRSAM1.
FT                                /FTId=PRO_0000055923.
FT   REPEAT       30     51       LRR 1.
FT   REPEAT       56     77       LRR 2.
FT   REPEAT       82    103       LRR 3.
FT   REPEAT      105    127       LRR 4.
FT   REPEAT      128    149       LRR 5.
FT   REPEAT      151    172       LRR 6.
FT   DOMAIN      569    632       SAM. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00184}.
FT   ZN_FING     675    710       RING-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   COILED      254    380       {ECO:0000255}.
FT   COILED      510    562       {ECO:0000255}.
FT   MOTIF       649    652       PTAP motif 1.
FT   MOTIF       661    664       PTAP motif 2.
FT   MOD_RES     234    234       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     604    604       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   VAR_SEQ       1    420       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_012660.
FT   VAR_SEQ     474    500       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_012661.
FT   VARIANT     318    318       N -> D (in dbSNP:rs1539567).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_021051.
FT   VARIANT     694    694       C -> R (in CMT2P; abolishes interaction
FT                                with FUS; dbSNP:rs759312530).
FT                                {ECO:0000269|PubMed:27615052}.
FT                                /FTId=VAR_077460.
FT   VARIANT     694    694       C -> Y (in CMT2P; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:27686364}.
FT                                /FTId=VAR_077461.
FT   MUTAGEN     649    664       Missing: Abolishes interaction with
FT                                TSG101. {ECO:0000269|PubMed:15256501}.
FT   MUTAGEN     675    675       C->A: Abolishes ubiquitination of TSG101.
FT                                {ECO:0000269|PubMed:15256501}.
FT   MUTAGEN     692    692       H->A: Abolishes ubiquitination of TSG101.
FT                                {ECO:0000269|PubMed:15256501}.
FT   CONFLICT    385    385       V -> F (in Ref. 2; BAB71119).
FT                                {ECO:0000305}.
FT   CONFLICT    402    402       I -> V (in Ref. 2; BAC03703).
FT                                {ECO:0000305}.
SQ   SEQUENCE   723 AA;  83594 MW;  4A59461C92467BB1 CRC64;
     MPLFFRKRKP SEEARKRLEY QMCLAKEAGA DDILDISKCE LSEIPFGAFA TCKVLQKKVL
     IVHTNHLTSL LPKSCSLLSL ATIKVLDLHD NQLTALPDDL GQLTALQVLN VERNQLMQLP
     RSIGNLTQLQ TLNVKDNKLK ELPDTVGELR SLRTLNISGN EIQRLPQMLA HVRTLEMLSL
     DASAMVYPPR EVCGAGTAAI LQFLCKESGL EYYPPSQYLL PILEQDGIEN SRDSPDGPTD
     RFSREELEWQ NRFSDYEKRK EQKMLEKLEF ERRLELGQRE HTQLLQQSSS QKDEILQTVK
     EEQSRLEQGL SEHQRHLNAE RQRLQEQLKQ TEQNISSRIQ KLLQDNQRQK KSSEILKSLE
     NERIRMEQLM SITQEETESL RRRDVASAMQ QMLTESCKNR LIQMAYESQR QNLVQQACSS
     MAEMDERFQQ ILSWQQMDQN KAISQILQES AMQKAAFEAL QVKKDLMHRQ IRSQIKLIET
     ELLQLTQLEL KRKSLDTESL QEMISEQRWA LSSLLQQLLK EKQQREEELR EILTELEAKS
     ETRQENYWLI QYQRLLNQKP LSLKLQEEGM ERQLVALLEE LSAEHYLPIF AHHRLSLDLL
     SQMSPGDLAK VGVSEAGLQH EILRRVQELL DAARIQPELK PPMGEVVTPT APQEPPESVR
     PSAPPAELEV QASECVVCLE REAQMIFLNC GHVCCCQQCC QPLRTCPLCR QDIAQRLRIY
     HSS
//
